证券代码:300622 证券简称:博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 | --- | --- | |--------------|--------------------------------------------------------| | | 编号:2023-013 | | | 特定对象调研 分析师会议 | | | 业绩说明会 | | 投资者关系活 | | | | 路演活动 | | 动类别 | | | | | | | 电话会议 | | 参与单位名称 | 国盛证券、嘉实基金、华泰柏瑞、永赢基金 | | 时间 | 月 7 日 | | 地点 | | | | 董事、董事会秘书、副总经理:杨秋 | | 上市公司接待 | | | | 高级经理:蔡百合 | | 人员姓名 | | | | 证券事务代表:方敏睿 | | | 1、Q:请介绍一下公司目前的品牌矩阵? | | | :公司一直重视品牌体系建设,坚持将消费者需求放在 | | | 首位,为满足不同客群的多场景消费需求,公司积极打造六大 | | | 眼镜零售品牌进行多层次市场布局,形成差异化品牌矩阵效 | | | President opti ...

证券代码:300622 证券简称:博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 | --- | --- | |--------------|-------------------------------------------| | | 特定对象调研 | | | 媒体采访 | | 投资者关系活 | | | | 新闻发布会 | | 动类别 | | | | 现场参观 | | | 其他 电话会议 | | | | | | | | 参与单位名称 | | | | | | | 光大证券 | | 时间 | 2023 年 9 月 6 日 | | 地点 | 公司会议室 | | | 董事、董事会秘书、副总经理:杨秋 | | 上市公司接待 | 镜联易购董事长:夏伟奇 | | 人员姓名 | IR 高级经理:蔡百合 | | | 证券事务代表:方敏睿 | | | 1、Q | | | A:公司实际控制人及创始人 | | | FAN | | 投资者关系活 | | | 动主要内容介 | 于外国投资者并购境内企业的规定》(商务部令 | | 绍 | 号)等有关法律法规, | | | | | | | | | | 1 | --- | |-- ...

证券代码:300622 证券简称:博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|----------------------------------------|------------| | | | 编号: | | | 特定对象调研 | 分析师会议 | | | 媒体采访 | 业绩说明会 | | 投资者关系活 | | | | | 新闻发布会 | 路演活动 | | 动类别 | | | | | 现场参观 | | | | 其他 策略会、电话会议 | | | | | | | 参与单位名称 | | | | | 裕晋投资、深圳红方、西部利得、上海观火 | | | 时间 | 2023 年 9 月 5 日 | | | 地点 | 公司会议室 | | | | 董事、董事会秘书、副总经理:杨秋 | | | 上市公司接待 | | | | | IR 高级经理:蔡百合 | | | 人员姓名 | | | | | 证券事务代表:方敏睿 | | | | 1、Q | | | | 所调整? | | | | A | | | | | | | | | | | 投资者关系 ...

证券代码:300622 证券简称:博士眼镜 | --- | --- | |--------------|-------------------------------------------------------| | | 编号:2023-010 | | | 分析师会议 | | | 业绩说明会 | | 投资者关系活 | | | | 路演活动 | | 动类别 | | | | | | | 电话会议 | | 参与单位名称 | 华富基金、万家基金、建信基金、国泰君安 | | 时间 | | | 地点 | | | 上市公司接待 | | | 人员姓名 | | | | 年上半年直营门店开店、闭店数量相当,导 | | | 致整体门店数量增长不及预期,想请公司简单介绍下后续开 | | | | | | 年上半年,消费市场延续疲弱,公司采取相对谨 | | | 慎的开店扩张策略,重点围绕华东、华南、西南等优势市场的 | | | 优质商超体系稳扎稳打。目前,新开店质量基本满足预期,下 | | 投资者关系活 | 半年公司也将保持较为谨慎的开店思路,预计 2023 年全年净 | | 动主要内容介 | 家左右。公司认为随着经济运行整体趋稳, ...

证券代码：300622 证券简称：博士眼镜 | --- | --- | |--------------|----------------------------------------------------------| | | 编号：2023-009 | | | 分析师会议 | | | 业绩说明会 | | 投资者关系活 | | | | 路演活动 | | 动类别 | | | | | | | | | | 东北证券、东方自营、敦和资产、复胜资产、富国基金、广银 | | | 理财、国金证券、国联安基金、国融基金、国盛证券、国泰君 | | | 安、和谐汇一资产、华创证券、华福证券、华商基金、华泰柏 | | | 瑞、华泰自营、华夏久盈、幻方投研、汇添富、嘉实基金、交 | | | 银基金、景顺长城基金、开源证券、路博迈、民生证券、明河 | | 参与单位名称 | 投资、明世伙伴基金、南方基金、人保资产、睿郡投资、申万 | | | 菱信、申万宏源、金泊投资、泰达宏利、西部利得、汐泰投资、 | | | 新活力资本、信达证券、兴业基金、益菁汇、银河自营、盈峰 | | | 资本、源峰基金、长盛基金、招商证券、浙商证券、智诚海威、 ...

Financial Performance - The company reported a revenue of RMB 500 million for the first half of 2023, representing a year-on-year increase of 15%[14]. - The company's operating revenue for the reporting period reached ¥598,896,173.14, representing a 30.98% increase compared to ¥457,231,592.83 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was ¥66,567,163.98, a significant increase of 229.74% from ¥20,187,677.23 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was ¥62,651,426.01, reflecting a 311.85% increase compared to ¥15,212,265.00 in the same period last year[21]. - Basic earnings per share rose to ¥0.39, up 225.00% from ¥0.12 in the same period last year[21]. - The company achieved a total of 87.99 million yuan in online group coupon transactions, a year-on-year increase of 89.39%[61]. - The company reported a significant increase in income tax expenses by 197.25% to CNY 14,886,429.63 due to improved performance[83]. - The total comprehensive income for the period was CNY 70,826,486.57, compared to CNY 21,968,540.87 in the previous year[194]. Store Expansion and Retail Operations - The number of retail stores increased to 1,200, with a net addition of 100 stores in the first half of 2023[14]. - The company operates a total of 513 stores as of June 30, 2023, with 492 being directly operated and 21 franchised[50]. - The company opened 24 new stores during the reporting period, including 23 direct-operated stores and 1 traditional franchise store, while closing 24 stores, resulting in a total of 513 stores as of June 30, 2023[69]. - Direct-operated stores generated a total revenue of approximately ¥482.11 million, accounting for 80.50% of the company's total revenue, while traditional franchise stores contributed approximately ¥1.59 million, representing 0.27% of total revenue[70]. - The company has expanded its store network across 24 provinces, municipalities, and autonomous regions in China, enhancing its market presence[69]. Product Development and Innovation - The company plans to launch three new product lines in Q3 2023, focusing on smart eyewear technology[14]. - The company is actively engaged in the development of new products and technologies, although specific details are not provided in the report[96]. - The company has launched 41 co-branded eyewear products with well-known brands during the reporting period[62]. - The company is investing in new technology development to improve operational efficiency and customer experience[103]. Market Trends and Consumer Behavior - User data showed a 20% increase in active customers, reaching 2 million by the end of June 2023[14]. - The company reported a significant increase in the number of consumers owning two or more pairs of glasses, reaching 76% in 2022, a year-on-year growth of 23.9%[40]. - The overall myopia rate among children and adolescents in China was 53.6% in 2022, up 0.9% from 2021, highlighting a rising need for myopia prevention lenses[38]. - The market for functional eyewear is diversifying, with consumers increasingly valuing aesthetics and quality alongside corrective functions[40]. Strategic Initiatives and Future Outlook - Future guidance estimates a revenue growth of 10-15% for the full year 2023[14]. - The company is exploring potential acquisitions to expand its market presence in Southeast Asia[14]. - The management highlighted the importance of adapting to market competition and enhancing customer experience as key strategies moving forward[14]. - The company is focusing on expanding its market presence in core urban areas and exploring new opportunities in duty-free business in Hainan[49]. - The company is actively collaborating with schools, government, and medical institutions to improve national vision health and promote a new optical service system[45]. Operational Efficiency and Cost Management - Operational costs increased by 5% due to rising material prices, but the company aims to optimize supply chain efficiency[14]. - The company's procurement model involves centralized purchasing and dynamic supplier management to optimize product offerings[34]. - The company has established long-term stable partnerships with major suppliers, including Kering Group and Essilor, enhancing its supply chain management[79]. - The company has implemented a digital supply chain strategy to improve order processing capabilities and delivery efficiency[79]. Employee Engagement and Training - The company has implemented a competitive incentive mechanism to enhance employee engagement and stability, as part of its talent development strategy[66]. - The company conducted 4 professional training sessions in optical fields, training a total of 80 employees during the reporting period[67]. - The company has established partnerships with 12 educational institutions, including Chuanbei Medical College and Shenzhen Pengcheng Technician College, to enhance talent recruitment and training efforts[65]. Financial Management and Investments - The company has committed CNY 7,500,000 to bank wealth management products and CNY 200,000 to broker wealth management products, totaling CNY 12,500,000 in outstanding balances[101]. - The total investment amount for the reporting period reached ¥86,990,314.31, compared to ¥0.00 in the same period last year, indicating a significant increase[91]. - The company reported a major equity investment of ¥22,939,528, representing a 68.0% ownership stake in the associated entity[92]. - The company has not engaged in derivative investments or entrusted loans during the reporting period[105][106]. Corporate Governance and Shareholder Engagement - The company held its annual general meeting on May 19, 2023, with an investor participation rate of 47.43%[118]. - No cash dividends or stock bonuses will be distributed for the semi-annual period, and no capital reserve will be converted into share capital[120]. - The company actively engages with investors through various communication channels, ensuring transparency and timely information disclosure[128]. Challenges and Risks - The company is facing risks from macroeconomic fluctuations that could impact consumer spending and overall demand for its products, necessitating strategic adjustments[110]. - The company is experiencing a gradual increase in registered users on its digital platform, although converting these users into active customers poses a challenge[113]. - The company acknowledges the risk of talent shortages due to intense competition for skilled professionals in the retail sector[113].

博士眼镜连锁股份有限公司 2023 年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位：元 非经营性资金占用 资金占用方名称 占用方与 上市公司 的关联关 系 上市公 司核算 的会计 科目 2023 年期初占 用资金余额 2023 年半年度 占用累计发生 金额（不含利 息） 2023 年半 年度占用资 金的利息 （如有） 2023 年半年度 偿还累计发生 金额 2023 年半年 度期末占用资 金余额 占用形成原 因 占用性质 控股股东、实际控 制人及其附属企业 小计 - - - - 前控股股东、实际 控制人及其附属企 业 小计 - - - - 其他关联方及其附 属企业 小计 - - - - 总计 - - - - 其它关联资金往来 资金往来方名称 往来方与 上市公司 的关联关 系 上市公 司核算 的会计 科目 2023 年期初往 来资金余额 2023 年半年度 往来累计发生 金额（不含利 息） 2023 年半 年度往来资 金的利息 （如有） 2023 年半年度 偿还累计发生 金额 2023 年半年 度期末往来资 金余额 往来形成原 因 往来性质 （经营性往 来、非经营性 往来） 控股股东、实际控 法定代 ...

本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：300622 证券简称：博士眼镜 公告编号：2023-041 一、董事会会议召开情况 博士眼镜连锁股份有限公司（以下简称"公司"）第四届董事会第二十一次 会议通知于 2023 年 8 月 17 日以电子邮件的形式发出，会议于 2023 年 8 月 28 日 上午 10:30 在公司会议室以现场结合通讯表决等方式召开。本次会议应参与表决 董事 9 人，实际参与表决董事 9 人，会议由董事长 ALEXANDER LIU 先生召集和主 持，公司全体监事及高级管理人员列席会议。本次会议的召开符合有关法律、行 政法规、部门规章、规范性文件和《公司章程》的规定。 博士眼镜连锁股份有限公司 第四届董事会第二十一次会议决议公告 二、董事会会议审议情况 1、审议通过《关于<2023 年半年度报告>全文及摘要的议案》 表决结果：9 票同意、0 票反对、0 票弃权 经审议，董事会认为公司《2023 年半年度报告》及摘要的编制和审议程序符 合法律、行政法规、中国证监会和深圳证券交易所的相关规定，报告内容真实、 准确、完整地反映 ...

博士眼镜连锁股份有限公司章程 博士眼镜连锁股份有限公司章程 第一章 总则 第一条 为维护公司、股东和债权人的合法权益，规范公司的组织和行为，根 据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》 （以下简称《证券法》）和其他有关规定，制订本章程。 第二条 博士眼镜连锁股份有限公司系依照《公司法》和其他有关规定成立的 股份有限公司（以下简称"公司"）。 公司系由深圳市博士眼镜连锁有限公司按截止 2011 年 11 月 30 日经审计的原 账面净资产值折股整体变更设立的股份有限公司，在深圳市市场监督管理局注册登 记，取得营业执照，统一社会信用代码为 914403002793301026。 第三条 公司于 2017 年 2 月 10 日经中国证券监督管理委员会（以下简称中国 证监会）核准，首次向社会公众公开发行人民币普通股 2,145 万股，于 2017 年 3 月 15 日在深圳证券交易所创业板上市。 第四条 公司注册名称（中文）：博士眼镜连锁股份有限公司。 公司的英文名称：DOCTORGLASSES CHAIN CO.,LTD. 第五条 公司住所：深圳市罗湖区深南东路 5016 号京基一 ...

博士眼镜连锁股份有限公司投资者关系管理制度 博士眼镜连锁股份有限公司 投资者关系管理制度 第一章 总 则 第一条 为了切实加强博士眼镜连锁股份有限公司（以下简称"公司"）与投资 者和潜在投资者（以下统称"投资者"）之间的沟通，促进投资者对公司的了解， 进一步完善公司法人治理结构，提升公司的投资价值，实现公司价值和股东利益最 大化，根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司投资 者关系管理工作指引》《深圳证券交易所创业板股票上市规则》《深圳证券交易所 上市公司自律监管指引第2号—创业板上市公司规范运作》等有关法律法规、规范性 文件以及《博士眼镜连锁股份有限公司章程》（以下简称"《公司章程》"）的有 关规定，结合公司实际情况，特制定本制度。 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动交流 和诉求处理等工作，加强与投资者及潜在投资者之间的沟通，增进投资者对公司了 解和认同，以提升公司治理水平和企业整体价值，实现尊重投资者、回报投资者、 保护投资者目的的相关活动。 第三条 投资者关系管理工作的目的： （一）促进公司与投资者之间的良性关系，增进投资者对公司的了解和认同； （二 ...